The drop-off in severe cases among Americans 65 and older is especially encouraging because senior citizens have accounted for about 8 out of 10 deaths from the virus since it hit the U.S., where the toll stands at about 570,000.
The number of Americans applying for unemployment aid fell last week to 547,000, a new low since the pandemic struck and a further encouraging sign that layoffs are slowing on the strength of an improving job market.
The U.S. is set to meet President Joe Biden’s latest vaccine goal of administering 200 million coronavirus shots in his first 100 days in office, as the White House steps up its efforts to inoculate the rest of the public.
The European Medicines Agency made its determination after examining a small number of clot cases in people vaccinated in the U.S. It said these problems should be considered “very rare side effects of the vaccine.”
The United States will likely move to resume Johnson & Johnson’s COVID-19 vaccine this coming week, possibly with restrictions or broader warnings after reports of some very rare blood clot cases, the government’s top infectious diseases expert said Sunday.
The new effort, which relies on money approved by Congress as part of President Joe Biden’s coronavirus relief package, aims to break what experts say is a feast-or-famine cycle in U.S. preparedness for biological threats, of which the coronavirus is only one example.